Passage BIO, Inc.
PASG- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001787297
In the last 90 days, Passage BIO, Inc. insiders filed 1 open-market purchase and 0 sales; 29 institutions reported holding it in 13F filings for Q2 2026, worth $6.82M in total; no superinvestor holds it.
13F holders, Q4 2025
Institutional positions in Passage BIO, Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 30
- −1 vs. Q3 2025
- Shares held
- 1.58M
- +15.9K (+1.0%) vs. Q3 2025
- Total value
- $18.6M
- +$6.06M (+48.3%) vs. Q3 2025
- New holders
- 6
- 5 more added
- Sold out
- 7
- 6 more reduced
1 institution that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PASG on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 29 | $6.82M |
| Q1 2026 | 35 | $13.8M |
| Q4 2025 | 30 | $18.6M |
| Q3 2025 | 32 | $13.2M |
| Q2 2025 | 41 | $33.0M |
| Q1 2025 | 42 | $12.8M |
| Q4 2024 | 46 | $21.6M |
| Q3 2024 | 45 | $27.1M |
| Q2 2024 | 45 | $32.0M |
| Q1 2024 | 51 | $54.4M |
| Q4 2023 | 52 | $33.1M |
| Q3 2023 | 51 | $21.3M |
| Q2 2023 | 56 | $31.4M |
| Q1 2023 | 59 | $34.1M |
| Q4 2022 | 68 | $51.6M |
| Q3 2022 | 76 | $49.3M |
| Q2 2022 | 87 | $99.6M |
| Q1 2022 | 110 | $133.2M |
| Q4 2021 | 102 | $277.7M |
| Q3 2021 | 103 | $419.1M |
| Q2 2021 | 102 | $558.8M |
| Q1 2021 | 90 | $786.5M |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding Passage BIO, Inc.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Lynx1 Capital Management LP | 623,704 | $7.36M | 1.49% | 00.0% | Unchanged |
| Vestal Point Capital, LP | 305,000 | $3.60M | 0.13% | 00.0% | Unchanged |
| Vanguard Group Inc | 126,645 | $1.49M | 0.00% | +9,615+8.2% | Added |
| Eversept Partners, LP | 126,230 | $1.49M | 0.08% | +126,230 | New |
| Renaissance Technologies LLC | 109,089 | $1.29M | 0.00% | +8,300+8.2% | Added |
| Erste Asset Management GmbH | 85,262 | $1.00M | 0.01% | −37,528−30.6% | Reduced |
| Yiheng Capital Management, L.P. | 34,301 | $404.8K | 0.18% | +34,301 | New |
| Geode Capital Management, LLC | 31,397 | $370.6K | 0.00% | +4,114+15.1% | Added |
| BlackRock, Inc. | 28,903 | $341.1K | 0.00% | −846−2.8% | Reduced |
| Acadian Asset Management LLC | 24,196 | $284.0K | 0.00% | −1,372−5.4% | Reduced |
| Citadel Advisors LLC | 17,660 | $208.4K | 0.00% | −1,431−7.5% | Reduced |
| Northern Trust Corp | 14,217 | $167.8K | 0.00% | +14,217 | New |
| Quadrature Capital Ltd | 12,578 | $148.4K | 0.00% | +12,578 | New |
| Squarepoint Ops LLC | 10,799 | $127.4K | 0.00% | −12,701−54.0% | Reduced |
| Fiduciary Trust Co | 10,750 | $126.8K | 0.00% | 00.0% | Unchanged |
| Nano Cap New Millennium Growth Fund L P | 10,000 | $118.0K | 0.10% | +10,000 | New |
| Morgan Stanley | 4,275 | $50.4K | 0.00% | +3,937+1,164.8% | Added |
| UBS Group AG | 1,442 | $17.0K | 0.00% | +1,425+8,382.4% | Added |
| Rockefeller Capital Management L.P. | 500 | $5.90K | 0.00% | +500 | New |
| Barclays PLC | 212 | $2.50K | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 142 | $1.68K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 28 | $331 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 20 | $236 | 0.00% | 00.0% | Unchanged |
| Parallel Advisors, LLC | 16 | $189 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 15 | $177 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 12 | $142 | 0.00% | 00.0% | Unchanged |
| LRI Investments, LLC | 12 | $142 | 0.00% | 00.0% | Unchanged |
| Harbour Investments, Inc. | 3 | $35 | 0.00% | 00.0% | Unchanged |
| CWM, LLC | 1 | $0 | 0.00% | −1−50.0% | Reduced |
| TSFG, LLC | 5 | $0 | 0.00% | 00.0% | Unchanged |
| Tang Capital Management LLC | 0 | $0 | 0.00% | −75,000−100.0% | Sold out |
| OrbiMed Advisors LLC | 0 | $0 | 0.00% | −59,046−100.0% | Sold out |
| Bridgeway Capital Management, LLC | 0 | $0 | 0.00% | −20,803−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −289−100.0% | Sold out |
| MAI Capital Management | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −77−100.0% | Sold out |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| New Leaf Venture Partners, L.L.C. | – | – | – | – | Not filed |